PMID- 36191536 OWN - NLM STAT- MEDLINE DCOM- 20221025 LR - 20221207 IS - 1878-0334 (Electronic) IS - 1871-4021 (Linking) VI - 16 IP - 10 DP - 2022 Oct TI - Predictors of postpartum glucose metabolism disorders in women with gestational diabetes mellitus. PG - 102629 LID - S1871-4021(22)00243-0 [pii] LID - 10.1016/j.dsx.2022.102629 [doi] AB - BACKGROUND AND AIMS: Postpartum glucose metabolism disorders are a common problem in women with gestational diabetes mellitus (GDM). They are often underdiagnosed since many patients do not attend the postpartum screening. This study aims to assess predictors of postpartum glucose metabolism disorders and type 2 diabetes mellitus (T2DM) after GDM. MATERIAL AND METHODS: Retrospective study in women with GMD who underwent postpartum screening for glucose metabolism disorders (n = 2688). Logistic regression was used in the statistical analysis. RESULTS: 24.6% of women had postpartum glucose metabolism disorder. In multivariate analysis, pre-pregnancy body mass index (BMI) 25-30 kg/m(2) (OR 1.46, 95%CI 1.05 to 2.02) or BMI >/=30 kg/m(2) (OR 2.62, 95%CI 1.72 to 3.96), diagnosis of GDM before 20 weeks of pregnancy (OR 2.33, 95%CI 1.57 to 3.46), fasting plasma glucose after diagnosis of GDM >/=90 mg/dl (OR 2.12, 95%CI 1.50 to 2.98), postprandial glucose >/=100 mg/dl (OR 1.47, 95%CI 1.09 to 2.99), and HbA1c in the third trimester of pregnancy >/=5.3% (2.04, 95%CI, 1.52 to 2.75) were independent predictors for any postpartum glucose metabolism disorder. CONCLUSION: postpartum screening for T2DM should be performed in all women with GDM, and it is especially important not to lose follow-up in those with one or more predictive factors. CI - Copyright (c) 2022 Diabetes India. Published by Elsevier Ltd. All rights reserved. FAU - Garcia-Moreno, Rosa M AU - Garcia-Moreno RM AD - Department of Endocrinology and Nutrition, Hospital Universitario La Paz, Madrid, Spain. Electronic address: rosagarcia2812@gmail.com. FAU - Benitez-Valderrama, Pamela AU - Benitez-Valderrama P AD - Department of Endocrinology and Nutrition, Hospital Universitario La Paz, Madrid, Spain. FAU - Barquiel, Beatriz AU - Barquiel B AD - Department of Endocrinology and Nutrition, Hospital Universitario La Paz, Madrid, Spain. FAU - Hillman, Natalia AU - Hillman N AD - Department of Endocrinology and Nutrition, Hospital Universitario La Paz, Madrid, Spain. FAU - Herranz, Lucrecia AU - Herranz L AD - Department of Endocrinology and Nutrition, Hospital Universitario La Paz, Madrid, Spain. FAU - Perez-de-Villar, Noemi Gonzalez AU - Perez-de-Villar NG AD - Department of Endocrinology and Nutrition, Hospital Universitario La Paz, Madrid, Spain. LA - eng PT - Journal Article DEP - 20220923 PL - Netherlands TA - Diabetes Metab Syndr JT - Diabetes & metabolic syndrome JID - 101462250 RN - 0 (Blood Glucose) RN - 0 (Glycated Hemoglobin A) SB - IM MH - Pregnancy MH - Humans MH - Female MH - *Diabetes, Gestational/diagnosis/epidemiology MH - Glucose Tolerance Test MH - Blood Glucose/metabolism MH - Glycated Hemoglobin/metabolism MH - *Diabetes Mellitus, Type 2/complications/epidemiology MH - Retrospective Studies MH - Postpartum Period MH - Risk Factors OTO - NOTNLM OT - Gestational diabetes mellitus OT - Glucose metabolism disorder OT - Postpartum OT - Predictors OT - Type 2 diabetes mellitus COIS- Declaration of competing interest The authors declare that there is no conflict of interest regarding the publication of this paper. EDAT- 2022/10/04 06:00 MHDA- 2022/10/26 06:00 CRDT- 2022/10/03 18:28 PHST- 2022/03/04 00:00 [received] PHST- 2022/09/13 00:00 [revised] PHST- 2022/09/15 00:00 [accepted] PHST- 2022/10/04 06:00 [pubmed] PHST- 2022/10/26 06:00 [medline] PHST- 2022/10/03 18:28 [entrez] AID - S1871-4021(22)00243-0 [pii] AID - 10.1016/j.dsx.2022.102629 [doi] PST - ppublish SO - Diabetes Metab Syndr. 2022 Oct;16(10):102629. doi: 10.1016/j.dsx.2022.102629. Epub 2022 Sep 23.